In clinical studies of GLP-1RA plus SGLT2i combination therapy, the safety profile of the combination therapy was consistent with those of the individual agents, with no unexpected findings [9]
Specifically, ferulic acid has been shown to bind GLP-1 and inhibit dipeptidyl peptidase-4 (DPP-4), the enzyme responsible for its rapid inactivation, thereby extending the hormones biological activity. Nutrients 2025, 17, 625
PRR, proportional reporting ratio
Room temperature exposure should be limited to brief handling or shipping periods only
Please note, the compounded medication you may receive is not affiliated with Novo Nordisk or their brand-name drugs Wegovy and Ozempic
Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer